Cypress Capital Management LLC (Wy) Lantheus Holdings, Inc. Transaction History

Cypress Capital Management LLC (Wy)

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 08, 2018	SELL	$13.65 - $18.7 $333,947 - $457,495	-24,465 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$14.85 - $24.3 $15,889 - $26,001	1,070 Added 4.57%	24,465 $389,000
Q4 2017 Jan 31, 2018	BUY	$17.4 - $23.4 $33,321 - $44,811	1,915 Added 8.92%	23,395 $478,000
Q3 2017 Nov 07, 2017	BUY	$15.5 - $19.15 $332,940 - $411,341	21,480	21,480 $382,000

538

68.3M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $5.28B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Cypress Capital Management LLC (Wy), based on Form 13F filings with the SEC.

Stay updated on Cypress Capital Management LLC (Wy) with notifications on news.